Joaquim Barreto

642 total citations
35 papers, 406 citations indexed

About

Joaquim Barreto is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Joaquim Barreto has authored 35 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Joaquim Barreto's work include Diabetes Treatment and Management (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Parathyroid Disorders and Treatments (4 papers). Joaquim Barreto is often cited by papers focused on Diabetes Treatment and Management (9 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Parathyroid Disorders and Treatments (4 papers). Joaquim Barreto collaborates with scholars based in Brazil, United States and Italy. Joaquim Barreto's co-authors include Andrei C. Spósito, Alan T. Remaley, Sotirios K. Karathanasis, Luiz Sérgio Fernandes de Carvalho, Wilson Nadruz, Filipe A. Moura, Isabella Bonilha, Ilaria Zanotti, Alexandre Soares and Helison Rafael Pereira do Carmo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Joaquim Barreto

30 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joaquim Barreto Brazil 11 139 99 87 79 75 35 406
Stefano De Vuono Italy 14 73 0.5× 92 0.9× 157 1.8× 64 0.8× 151 2.0× 31 488
Lorenza Montagna Italy 11 172 1.2× 177 1.8× 107 1.2× 35 0.4× 88 1.2× 28 481
Magdalena Rysz-Górzyńska Poland 13 105 0.8× 111 1.1× 89 1.0× 36 0.5× 82 1.1× 17 414
Ravi Dave United States 5 263 1.9× 81 0.8× 312 3.6× 89 1.1× 106 1.4× 9 604
Nobuharu Fujiwara Japan 15 123 0.9× 92 0.9× 83 1.0× 52 0.7× 110 1.5× 19 497
Conghui Guan China 9 141 1.0× 168 1.7× 56 0.6× 48 0.6× 76 1.0× 16 508
Qian Zhuang China 13 84 0.6× 168 1.7× 97 1.1× 42 0.5× 56 0.7× 26 490
Teuku Heriansyah Indonesia 11 41 0.3× 87 0.9× 77 0.9× 33 0.4× 135 1.8× 59 392

Countries citing papers authored by Joaquim Barreto

Since Specialization
Citations

This map shows the geographic impact of Joaquim Barreto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joaquim Barreto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joaquim Barreto more than expected).

Fields of papers citing papers by Joaquim Barreto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joaquim Barreto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joaquim Barreto. The network helps show where Joaquim Barreto may publish in the future.

Co-authorship network of co-authors of Joaquim Barreto

This figure shows the co-authorship network connecting the top 25 collaborators of Joaquim Barreto. A scholar is included among the top collaborators of Joaquim Barreto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joaquim Barreto. Joaquim Barreto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Barreto, Joaquim, Isabella Bonilha, Alessandra M. Campos‐Staffico, et al.. (2024). Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design. Expert Opinion on Drug Safety. 24(12). 1471–1477. 2 indexed citations
2.
Barreto, Joaquim, et al.. (2024). Dapagliflozin reduces the white coat effect on systolic blood pressure of patients with type 2 diabetes: a post-hoc analysis from the ADDENDA-BHS 2 trial. Current Medical Research and Opinion. 41(1). 25–29. 1 indexed citations
3.
Barreto, Joaquim, et al.. (2024). Health literacy and diabetic retinopathy. Brazilian Journal of Medical and Biological Research. 57. e13066–e13066. 3 indexed citations
4.
Carmo, Helison Rafael Pereira do, Isabella Bonilha, Joaquim Barreto, et al.. (2024). High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction. International Journal of Molecular Sciences. 25(2). 1290–1290. 6 indexed citations
5.
Bonilha, Isabella, Helison Rafael Pereira do Carmo, Joaquim Barreto, et al.. (2024). Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial. International Journal of Molecular Sciences. 25(7). 4108–4108.
6.
Barreto, Joaquim, et al.. (2023). Diabetes-related distress and quality of life among people with type 2 diabetes at primary care level in Brazil. Acta Diabetologica. 61(4). 461–471. 1 indexed citations
7.
Barreto, Joaquim, Thiago Quinaglia, Otávio R. Coelho‐Filho, et al.. (2023). Carotid intima layer thickness but not intima-media thickness is related to coronary artery calcification in type 2 diabetes individuals: Results from the Brazilian diabetes study. Nutrition Metabolism and Cardiovascular Diseases. 33(12). 2384–2388. 1 indexed citations
8.
Barreto, Joaquim, et al.. (2023). Renal osteodystrophy and clinical outcomes: a prospective cohort study. Brazilian Journal of Nephrology. 46(2). e20230119–e20230119. 4 indexed citations
9.
Barreto, Joaquim, et al.. (2023). #2700 RENAL OSTEODYSTROPHY AND CLINICAL OUTCOMES: RESULTS FROM THE BRAZILIAN REGISTRY OF BONE BIOPSY. Nephrology Dialysis Transplantation. 38(Supplement_1). 2 indexed citations
10.
Barreto, Joaquim, et al.. (2023). Advanced Glycation End Products and Bone Metabolism in Patients with Chronic Kidney Disease. JBMR Plus. 7(3). 7 indexed citations
11.
Barreto, Joaquim, et al.. (2023). Pharmacokinetic Properties of Dapagliflozin in Hemodialysis and Peritoneal Dialysis Patients. Clinical Journal of the American Society of Nephrology. 18(8). 1051–1058. 15 indexed citations
12.
Barreto, Joaquim, et al.. (2023). Osteodistrofia renal e desfechos clínicos: um estudo de coorte prospectivo. Brazilian Journal of Nephrology. 46(2). 1 indexed citations
13.
Carvalho, Luiz Sérgio Fernandes de, Isabella Bonilha, Carlos Eduardo Barra Couri, et al.. (2022). Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis. Frontiers in Cardiovascular Medicine. 9. 876795–876795. 4 indexed citations
14.
Bonilha, Isabella, Joaquim Barreto, Guilherme Duprat Ceniccola, et al.. (2022). Aspirin in Primary Prevention and the Risk of Heart Failure: A Systematic Review and Meta-Analysis of Controlled Trials. ESC Heart Failure. 10(2). 1488–1491. 2 indexed citations
15.
Soares, Alexandre, Daniel Munhoz, Joaquim Barreto, et al.. (2021). Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial. Diabetes & Metabolism. 47(6). 101280–101280. 10 indexed citations
16.
Carvalho, Luiz Sérgio Fernandes de, Alexandre Soares, Joaquim Barreto, et al.. (2021). Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus. Nutrition and Diabetes. 11(1). 17–17. 8 indexed citations
17.
18.
Barreto, Joaquim, et al.. (2021). The impact of low income on long-term mortality of myocardial infarction patients: results from the Brazilian Heart Study. Current Medical Research and Opinion. 37(10). 1689–1695.
19.
Moura, Filipe A., Luiz Sérgio Fernandes de Carvalho, Joaquim Barreto, et al.. (2019). Inhibition of the sodium-glucose co-transporter 2 in the elderly: clinical and mechanistic insights into safety and efficacy. Revista da Associação Médica Brasileira. 65(1). 70–86. 17 indexed citations
20.
Barreto, Joaquim, Alexandre Soares, Wilson Nadruz, et al.. (2019). Prevalence, treatment, and control of dyslipidemia in diabetic participants of two brazilian cohorts: a place far from heaven. Revista da Associação Médica Brasileira. 65(1). 3–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano De Vuono Breakdown of academic impact, for papers by Lorenza Montagna Breakdown of academic impact, for papers by Magdalena Rysz-Górzyńska Breakdown of academic impact, for papers by Ravi Dave Breakdown of academic impact, for papers by Nobuharu Fujiwara Breakdown of academic impact, for papers by Conghui Guan Breakdown of academic impact, for papers by Qian Zhuang Breakdown of academic impact, for papers by Teuku Heriansyah
Rankless by CCL
2026